News & Insights

Deacons advises on HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited

Deacons recently represented Haitong International Securities Company Limited as underwriter in relation to the HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited.

Hua Han Bio-Pharmaceutical Holdings Limited is an investment holding company. It manufactures and sells pharmaceutical, medicinal healthcare and biopharmaceutical products. 

The team was led by partner Kelvan Cheung who was supported by associate Michelle Leung.

Related Services and Sectors:

Life Sciences and Healthcare

Filter News & Insights

Search News & Insights


Follow

Subscribe to Publications

Sign up for our regular updates covering the latest legal developments, regulations and case law.

Sign Up

Media Contact

For media enquiries please contact us at media.relations@deacons.com.

Tel: +852 2825 9211

Portfolio Builder

Select the legal services that you would like to download or add to the portfolio

Download    Add to portfolio   
Portfolio
Title Type CV Email

Remove All

Download


Click here to share this shortlist.
(It will expire after 30 days.)